These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 31175146

  • 1. Early Acid Suppression Therapy Exposure and Fracture in Young Children.
    Malchodi L, Wagner K, Susi A, Gorman G, Hisle-Gorman E.
    Pediatrics; 2019 Jul; 144(1):. PubMed ID: 31175146
    [Abstract] [Full Text] [Related]

  • 2. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
    Landi SN, Sandler RS, Pate V, Lund JL.
    Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
    [Abstract] [Full Text] [Related]

  • 3. A multicenter cohort analysis of fractures in histamine-2-receptor antagonist treated pediatric patients.
    Fleishman NR, Richardson T, Attard TM.
    Curr Med Res Opin; 2022 Apr; 38(4):565-570. PubMed ID: 35112645
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of children and adolescents first prescribed proton pump inhibitors or histamine-2-receptor antagonists: an observational cohort study.
    Ruigómez A, Kool-Houweling LMA, García Rodríguez LA, Penning-van Beest FJA, Herings RMC.
    Curr Med Res Opin; 2017 Dec; 33(12):2251-2259. PubMed ID: 28562108
    [Abstract] [Full Text] [Related]

  • 5. Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children's Hospitals.
    Slaughter JL, Stenger MR, Reagan PB, Jadcherla SR.
    J Pediatr; 2016 Jul; 174():63-70.e3. PubMed ID: 27131401
    [Abstract] [Full Text] [Related]

  • 6. Fracture risk of young adults receiving proton-pump inhibitors and H2-receptor antagonists.
    Fedida B, Schermann H, Ankory R, Rotman D, Shichman I, Yoffe V, Shlaifer A, Luger E.
    Int J Clin Pract; 2019 May; 73(5):e13339. PubMed ID: 30829427
    [Abstract] [Full Text] [Related]

  • 7. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
    Park JH, Lee J, Yu SY, Jung JH, Han K, Kim DH, Rhee J.
    BMC Geriatr; 2020 Oct 15; 20(1):407. PubMed ID: 33059626
    [Abstract] [Full Text] [Related]

  • 8. Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center.
    McCaleb RV, Gandhi AS, Clark SM, Clemmons AB.
    Ann Pharmacother; 2016 Jul 15; 50(7):541-7. PubMed ID: 27091869
    [Abstract] [Full Text] [Related]

  • 9. Long-term continuous use of proton-pump inhibitors is associated with renal function decline in patients without acute kidney injury.
    Hatakeyama Y, Horino T, Matsumoto T, Terada Y, Okuhara Y.
    Clin Exp Nephrol; 2021 Oct 15; 25(10):1087-1092. PubMed ID: 34089392
    [Abstract] [Full Text] [Related]

  • 10. Prenatal exposure to acid-suppressive drugs and the risk of childhood asthma: a population-based Danish cohort study.
    Andersen AB, Erichsen R, Farkas DK, Mehnert F, Ehrenstein V, Sørensen HT.
    Aliment Pharmacol Ther; 2012 May 15; 35(10):1190-8. PubMed ID: 22443179
    [Abstract] [Full Text] [Related]

  • 11. Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
    Shin GY, Park JM, Hong J, Cho YK, Yim HW, Choi MG.
    Am J Gastroenterol; 2021 Jun 01; 116(6):1211-1219. PubMed ID: 34074826
    [Abstract] [Full Text] [Related]

  • 12. Comparison of fracture risk between proton pump inhibitors and histamine-2 receptor antagonists in ANCA-associated vasculitis patients: a nested case-control study.
    Miyano S, Michihata N, Sada KE, Uda K, Matsui H, Fushimi K, Nangaku M, Yasunaga H.
    Rheumatology (Oxford); 2021 Apr 06; 60(4):1717-1723. PubMed ID: 33067623
    [Abstract] [Full Text] [Related]

  • 13. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
    Mattos ÂZ, Marchese GM, Fonseca BB, Kupski C, Machado MB.
    Arq Gastroenterol; 2017 Dec 06; 54(4):271-280. PubMed ID: 28954042
    [Abstract] [Full Text] [Related]

  • 14. Utilization and safety of proton-pump inhibitors and histamine-2 receptor antagonists in children and adolescents: an observational cohort study.
    Ruigómez A, Johansson S, Nagy P, García Rodríguez LA.
    Curr Med Res Opin; 2017 Dec 06; 33(12):2201-2209. PubMed ID: 28699796
    [Abstract] [Full Text] [Related]

  • 15. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
    Gerson LB, Robbins AS, Garber A, Hornberger J, Triadafilopoulos G.
    Am J Gastroenterol; 2000 Feb 06; 95(2):395-407. PubMed ID: 10685741
    [Abstract] [Full Text] [Related]

  • 16. Association Between Use of Acid-Suppressive Medications and Antibiotics During Infancy and Allergic Diseases in Early Childhood.
    Mitre E, Susi A, Kropp LE, Schwartz DJ, Gorman GH, Nylund CM.
    JAMA Pediatr; 2018 Jun 04; 172(6):e180315. PubMed ID: 29610864
    [Abstract] [Full Text] [Related]

  • 17. Proton Pump Inhibitors, But Not H2-receptor Antagonists, Are Associated With Incident Fractures Among Kidney Transplant Recipients.
    Lyu B, Jorgenson MR, Hansen KE, Djamali A, Astor BC.
    Transplantation; 2020 Dec 04; 104(12):2609-2615. PubMed ID: 32058466
    [Abstract] [Full Text] [Related]

  • 18. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.
    Freedberg DE, Haynes K, Denburg MR, Zemel BS, Leonard MB, Abrams JA, Yang YX.
    Osteoporos Int; 2015 Oct 04; 26(10):2501-7. PubMed ID: 25986385
    [Abstract] [Full Text] [Related]

  • 19. Acid Suppression and Antibiotics Administered during Infancy Are Associated with Celiac Disease.
    Boechler M, Susi A, Hisle-Gorman E, Rogers PL, Nylund CM.
    J Pediatr; 2023 Mar 04; 254():61-67.e1. PubMed ID: 36265574
    [Abstract] [Full Text] [Related]

  • 20. Associations between gastro-oesophageal reflux, its management and exacerbations of chronic obstructive pulmonary disease.
    Benson VS, Müllerová H, Vestbo J, Wedzicha JA, Patel A, Hurst JR, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators.
    Respir Med; 2015 Sep 04; 109(9):1147-54. PubMed ID: 26166017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.